The lawmakers questioned the company's moves in response to the pricing uproar.
The cigar guidelines address the health warnings manufacturers must place on their products.
OPINION | But corporate subsidies, legal and otherwise, won't fix a broken program.
The proposed rules could help address some insurer complaints.
He said the maker is exhibiting "greed" that is "shameful."
It marks a potential area for compromise with Republicans.
The company said a generic version will be available in "several weeks."
OPINION | The public needs more answers from the CDC.
OPINION | With appropriate action, we can curb the opioid epidemic.
OPINION | It's even more powerful than heroin, yet available with prescription.
The sweeping new recommendation highlights the concern over the largely unknown virus.
The EpiPen maker has faced an uproar over its price hikes.
OPINION | The dangers of mail order chicks.
Rep. Tim Murphy (R-Pa.) said parts of Clinton's plan are "very helpful."
The committee leaders have also asked that Mylan turn over documents.
He defended his decision to expand Medicaid under ObamaCare, blasting the "naysayers."
The FDA would like to initially lower the level of sodium consumption to 3,000 mg.
The senators accuse the DOJ of seeking leverage through its antitrust review.
CEO Heather Bresch also blamed insurance companies for increased consumer costs.
The EPA has previously attempted to ban asbestos.
Two Cabinet secretaries want Congress to lift the cap on Medicaid funds, among other steps.
Researchers who found a vulnerability in a medical device played the stock market.
"I didn't feel like I had any choice," says Tennessee’s insurance commissioner.
OPINION | Salmonella outbreaks on the rise because of backyard coops.